Aanika Biosciences
PrivateLast Round
Grant
May 31, 2023
Total Funding Raised
$15.9M
Company Overview
Aanika Biosciences operates in Healthcare & Life Sciences and is based in Brooklyn, New York. Its latest recorded funding round was a Grant round in May 2023.
Aanika Biosciences is a biotechnology company that provides supply chain traceability and risk management solutions using edible, microbial tags.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, InsurTech, Supply Chain Tracking, Compliance & Risk
Business Model
B2B
Customer Profile
Marketplace Commission, Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aanika Biosciences Comparables
Compare Aanika Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Index Biosystems | 83% | |
| Natural Trace | 79% | |
| TruTag Technologies | 73% |
For institutional investors. Book with your work email.
Aanika Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 31, 2023 | ||||
| Series A | Nov 30, 2021 | ||||
| Seed | Nov 20, 2019 | ||||
| Pre Seed | Feb 6, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aanika Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New York City Economic Development Corporation | Grant |
| Gaingels | Series A |
| ADIT Ventures | Series A |
| Draper Associates | Series A, Pre Seed, Seed |
| Adit Ventures | Series A |
| RebelBio | Seed |
| W11 Capital Management | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 31, 2023
$800K grant from New York City Economic Development Corporation.
- Nov 30, 2021
$12M round led by Adit Ventures.
For institutional investors. Book with your work email.
Aanika Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aanika Biosciences's valuation, stock price, and market status.
Is Aanika Biosciences a public or private company?
Aanika Biosciences is a private company.
What is the current stock price of Aanika Biosciences?
Aanika Biosciences is a private company, so its shares have no public market price. Caplight tracks Aanika Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aanika Biosciences worth (valuation)?
Valuation information for Aanika Biosciences is not publicly available.
Can I buy Aanika Biosciences stock?
Aanika Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aanika Biosciences's last funding round?
Aanika Biosciences's most recent funding round was Grant on May 31, 2023.
Who are the main investors in Aanika Biosciences?
Key investors in Aanika Biosciences include ADIT Ventures, Draper Associates, Adit Ventures.
Will Aanika Biosciences IPO soon?
No public IPO plans have been announced for Aanika Biosciences.
How can I track Aanika Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Aanika Biosciences's shares on secondary markets.